Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2020 Volume 20 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2020 Volume 20 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Puerarin protects vascular smooth muscle cells from oxidized low‑density lipoprotein‑induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways

  • Authors:
    • Yanwu Hu
    • Haitao Li
    • Ruili Li
    • Zijing Wu
    • Wenxin Yang
    • Wei Qu
  • View Affiliations / Copyright

    Affiliations: Department of Traditional Chinese Medicine, School of Medicine, Tonghua Normal University, Tonghua, Jilin 134002, P.R. China, Department of Pharmacy, Affiliated Hospital, Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China, Department of Pharmacy, Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, Jiangsu 214400, P.R. China
  • Article Number: 270
    |
    Published online on: October 27, 2020
       https://doi.org/10.3892/etm.2020.9400
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Puerarin belongs to the family of flavonoids extracted from Pueraria lobata (Wild.) Ohwi, which exhibits antioxidative, anti‑inflammatory, anti‑hyperglycemic, antitumor, anti‑hypertensive and anti‑atherosclerotic activities. In the present study, the effects of puerarin on oxidized low‑density lipoprotein (ox‑LDL)‑stimulated vascular smooth muscle cells (VSMCs) were explored to understand the mechanisms underlying the anti‑atherosclerotic effects of puerarin. VSMCs were treated with various concentrations of puerarin (0, 20, 40 and 80 µM) prior to stimulation with ox‑LDL (50 µg/ml). VSMC viability was evaluated by performing MTT and Cell Counting Kit‑8 assays. Moreover, superoxide dismutase (SOD) and malondialdehyde (MDA) levels were measured by performing ELISAs. The mRNA expression levels of interleukin‑6 (IL‑6) and tumor necrosis factor‑α (TNF‑α) were determined via reverse transcription‑quantitative PCR. Western blotting was conducted to assess the levels of p38‑MAPK and JNK phosphorylation. The results indicated that puerarin inhibited ox‑LDL‑induced VSMC viability. Moreover, puerarin significantly decreased the mRNA expression levels of IL‑6 and TNF‑α, significantly reduced the production of MDA and significantly increased SOD activity in ox‑LDL‑stimulated VSMCs. Puerarin also inhibited ox‑LDL‑induced phosphorylation of p38 and JNK in VSMCs. The results suggested that puerarin reduced ox‑LDL‑induced VSMC viability via inhibition of the p38 MAPK and JNK signaling pathways. The present study provided theoretical evidence that puerarin may serve as a therapeutic agent to reduce the development of atherosclerosis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Liu J, Ren Y, Kang L and Zhang L: Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin. Int J Mol Med. 33:1341–1347. 2014.PubMed/NCBI View Article : Google Scholar

2 

Dell'omo G, Penno G, Pucci L, Lucchesi D, Fotino C, Del Prato S and Pedrinelli R: ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension. Clin Sci (Lond). 111:357–364. 2006.PubMed/NCBI View Article : Google Scholar

3 

Zhu F, Li C, Jin XP, Weng SX, Fan LL, Zheng Z, Li WL, Wang F, Wang WF, Hu XF, et al: Celastrol may have an anti-atherosclerosis effect in a rabbit experimental carotid atherosclerosis model. Int J Clin Exp Med. 7:1684–1691. 2014.PubMed/NCBI

4 

Liu Z, Ren X, Yang Z, Zhao Y, Ji L, Li J and Yue W: Effects and mechanisms of indol-2,3-dione on atherosclerosis. Int J Clin Exp Med. 7:2087–2091. 2014.PubMed/NCBI

5 

Hu Y, Sun B, Liu K, Yan M, Zhang Y, Miao C and Ren L: Icariin attenuates high-cholesterol diet induced atherosclerosis in rats by inhibition of inflammatory response and p38 MAPK signaling pathway. Inflammation. 39:228–236. 2016.PubMed/NCBI View Article : Google Scholar

6 

González-Navarro H, Abu Nabah YN, Vinué A, Andrés-Manzano MJ, Collado M, Serrano M and Andrés V: p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis. J Am Coll Cardiol. 55:2258–2268. 2010.PubMed/NCBI View Article : Google Scholar

7 

Daemen MJ, Lombardi DM, Bosman FT and Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 68:450–456. 1991.PubMed/NCBI View Article : Google Scholar

8 

Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:801–809. 1993.PubMed/NCBI View Article : Google Scholar

9 

Yan LP, Chan SW, Chan AS, Chen SL, Ma XJ and Xu HX: Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sci. 79:324–330. 2006.PubMed/NCBI View Article : Google Scholar

10 

Fu J, Jing W, Wang W, Chen S, Zhang J and Liu A: A novel and effective chromatographic approach to the separation of isoflavone derivatives from Pueraria lobata. Molecules. 20:4238–4253. 2015.PubMed/NCBI View Article : Google Scholar

11 

Zhu X, Xie M, Wang K, Zhang K, Gao Y, Zhu L and Zhou F: The effect of puerarin against IL-1β-mediated leukostasis and apoptosis in retinal capillary endothelial cells (TR-iBRB2). Mol Vis. 20:1815–1823. 2014.PubMed/NCBI

12 

Bao MH, Zhang YW, Lou XY, Xiao Y, Cheng Y and Zhou HH: Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS. Can J Physiol Pharmacol. 92:299–306. 2014.PubMed/NCBI View Article : Google Scholar

13 

Meng XH, Ni C, Zhu L, Shen YL, Wang LL and Chen YY: Puerarin protects against high glucose-induced acute vascular dysfunction: Role of heme oxygenase-1 in rat thoracic aorta. Vascul Pharmacol. 50:110–115. 2009.PubMed/NCBI View Article : Google Scholar

14 

Yang X, Hu W, Zhang Q, Wang Y and Sun L: Puerarin inhibits C-reactive protein expression via suppression of nuclear factor kappaB activation in lipopolysaccharide-induced peripheral blood mononuclear cells of patients with stable angina pectoris. Basic Clin Pharmacol Toxicol. 107:637–642. 2010.PubMed/NCBI View Article : Google Scholar

15 

Hien TT, Kim HG, Han EH, Kang KW and Jeong HG: Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells. Mol Nutr Food Res. 54:918–928. 2010.PubMed/NCBI View Article : Google Scholar

16 

Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC and Cheng JT: Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod. 66:788–792. 2003.PubMed/NCBI View Article : Google Scholar

17 

Bao L, Zhang Y, Wei G, Wang Y, Ma R, Cheng R, Ren X and Agula B: The anti-atherosclerotic effects of puerarin on induced-atherosclerosis in rabbits. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 159:53–59. 2015.PubMed/NCBI View Article : Google Scholar

18 

Fu R, Zhang Y, Guo Y, Xu Y and Chen F: Digital gene expression analysis of the pathogenesis and therapeutic mechanisms of ligustrazine and puerarin in rat atherosclerosis. Gene. 552:75–80. 2014.PubMed/NCBI View Article : Google Scholar

19 

Chang WC, Yu YM, Chiang SY and Tseng CY: Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: Studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression. Br J Nutr. 99:709–714. 2008.PubMed/NCBI View Article : Google Scholar

20 

Hu Y, Liu K, Yan M, Zhang Y, Wang Y and Ren L: Icariin inhibits oxidized low-density lipoprotein-induced proliferation of vascular smooth muscle cells by suppressing activation of extracellular signal-regulated kinase 1/2 and expression of proliferating cell nuclear antigen. Mol Med Rep. 13:2899–2903. 2016.PubMed/NCBI View Article : Google Scholar

21 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

22 

Yasunari K, Kohno M, Kano H, Hanehira T, Minami M and Yoshikawa J: Anti-atherosclerotic action of vascular D1 receptors. Clin Exp Pharmacol Physiol Suppl. 26:S36–S40. 1999.PubMed/NCBI

23 

Witztum JL and Steinberg D: The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? Trends Cardiovasc Med. 11:93–102. 2001.PubMed/NCBI View Article : Google Scholar

24 

Guo LL, Chen YJ, Wang T, An J, Wang CN, Shen YC, Yang T, Zhao L, Zuo QN, Zhang XH, et al: Ox-LDL-induced TGF-β1 production in human alveolar epithelial cells: Involvement of the Ras/ERK/PLTP pathway. J Cell Physiol. 227:3185–3191. 2012.PubMed/NCBI View Article : Google Scholar

25 

Liao L, Zhou Q, Song Y, Wu W, Yu H, Wang S, Chen Y, Ye M and Lu L: Ceramide mediates Ox-LDL-induced human vascular smooth muscle cell calcification via p38 mitogen-activated protein kinase signaling. PLoS One. 8(e82379)2013.PubMed/NCBI View Article : Google Scholar

26 

Prasain JK, Peng N, Rajbhandari R and Wyss JM: The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice. Phytomedicine. 20:17–23. 2012.PubMed/NCBI View Article : Google Scholar

27 

Fu C, Chen B, Jin X, Liu X, Wang F, Guo R, Chen Z, Zheng H, Wang L and Zhang Y: Puerarin protects endothelial progenitor cells from damage of angiotensin II via activation of ERK1/2Nrf2 signaling pathway. Mol Med Rep. 17:3877–3883. 2018.PubMed/NCBI View Article : Google Scholar

28 

Gao Y, Wang X and He C: An isoflavonoid-enriched extract from Pueraria lobata (kudzu) root protects human umbilical vein endothelial cells against oxidative stress induced apoptosis. J Ethnopharmacol. 193:524–530. 2016.PubMed/NCBI View Article : Google Scholar

29 

Ji L, Du Q, Li Y and Hu W: Puerarin inhibits the inflammatory response in atherosclerosis via modulation of the NF-kappaB pathway in a rabbit model. Pharmacol Rep. 68:1054–1059. 2016.PubMed/NCBI View Article : Google Scholar

30 

Hu YW, Li HT, Liu K, Yan MT, Zhang Y and Ren LQ: Effects of icariin on proliferation of vascular smooth muscle cell induced by ox-LDL via impacting MAPK signaling pathway. Zhongguo Zhong Yao Za Zhi. 41:3655–3660. 2016.(In Chinese). PubMed/NCBI View Article : Google Scholar

31 

Li W, Zhi W, Zhao J, Yao Q, Liu F and Niu X: Cinnamaldehyde protects VSMCs against ox-LDL-induced proliferation and migration through S arrest and inhibition of p38, JNK/MAPKs and NF-κB. Vascul Pharmacol. 108:57–66. 2018.PubMed/NCBI View Article : Google Scholar

32 

Hu Y, Liu K, Bo S, Yan M, Zhang Y, Miao C and Ren L: Inhibitory effect of puerarin on vascular smooth muscle cells proliferation induced by oxidised low-density lipoprotein via suppressing ERK 1/2 phosphorylation and PCNA expression. Pharmazie. 71:89–93. 2016.PubMed/NCBI

33 

Wan Q, Liu Z and Yang Y: Puerarin inhibits vascular smooth muscle cells proliferation induced by fine particulate matter via suppressing of the p38 MAPK signaling pathway. BMC Complement Altern Med. 18(146)2018.PubMed/NCBI View Article : Google Scholar

34 

Yang X, Yang Y, Zhou S, Gong X, Dai Q, Zhang P and Jiang L: Puerarin stimulates osteogenic differentiation and bone formation through the ERK1/2 and p38-MAPK signaling pathways. Curr Mol Med. 17:488–496. 2018.PubMed/NCBI View Article : Google Scholar

35 

Wang M, Li Z, Zhang X, Xie X, Zhang Y, Wang X and Hou Y: Rosuvastatin attenuates atrial structural remodelling in rats with myocardial infarction through the inhibition of the p38 MAPK signalling pathway. Heart Lung Circ. 24:386–394. 2015.PubMed/NCBI View Article : Google Scholar

36 

Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM and Glembotski CC: p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem. 275:23814–23824. 2000.PubMed/NCBI View Article : Google Scholar

37 

Yang C, Liu W, Shan H, Yu X, Zhang X, Zeng B and Qian Y: Naringin inhibits titanium particles-induced up-regulation of TNF-α and IL-6 via the p38 MAPK pathway in fibroblasts from hip periprosthetic membrane. Connect Tissue Res. 1–10. 2020.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hu Y, Li H, Li R, Wu Z, Yang W and Qu W: Puerarin protects vascular smooth muscle cells from oxidized low‑density lipoprotein‑induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways. Exp Ther Med 20: 270, 2020.
APA
Hu, Y., Li, H., Li, R., Wu, Z., Yang, W., & Qu, W. (2020). Puerarin protects vascular smooth muscle cells from oxidized low‑density lipoprotein‑induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways. Experimental and Therapeutic Medicine, 20, 270. https://doi.org/10.3892/etm.2020.9400
MLA
Hu, Y., Li, H., Li, R., Wu, Z., Yang, W., Qu, W."Puerarin protects vascular smooth muscle cells from oxidized low‑density lipoprotein‑induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways". Experimental and Therapeutic Medicine 20.6 (2020): 270.
Chicago
Hu, Y., Li, H., Li, R., Wu, Z., Yang, W., Qu, W."Puerarin protects vascular smooth muscle cells from oxidized low‑density lipoprotein‑induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways". Experimental and Therapeutic Medicine 20, no. 6 (2020): 270. https://doi.org/10.3892/etm.2020.9400
Copy and paste a formatted citation
x
Spandidos Publications style
Hu Y, Li H, Li R, Wu Z, Yang W and Qu W: Puerarin protects vascular smooth muscle cells from oxidized low‑density lipoprotein‑induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways. Exp Ther Med 20: 270, 2020.
APA
Hu, Y., Li, H., Li, R., Wu, Z., Yang, W., & Qu, W. (2020). Puerarin protects vascular smooth muscle cells from oxidized low‑density lipoprotein‑induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways. Experimental and Therapeutic Medicine, 20, 270. https://doi.org/10.3892/etm.2020.9400
MLA
Hu, Y., Li, H., Li, R., Wu, Z., Yang, W., Qu, W."Puerarin protects vascular smooth muscle cells from oxidized low‑density lipoprotein‑induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways". Experimental and Therapeutic Medicine 20.6 (2020): 270.
Chicago
Hu, Y., Li, H., Li, R., Wu, Z., Yang, W., Qu, W."Puerarin protects vascular smooth muscle cells from oxidized low‑density lipoprotein‑induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways". Experimental and Therapeutic Medicine 20, no. 6 (2020): 270. https://doi.org/10.3892/etm.2020.9400
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team